ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

ACS Asks Reagan To Back Stronger Cigarette Warning

April 2, 1982

Should Be Cut First, DCT Board Says

December 4, 1981